Bullish Case: CRISPR Therapeutics has demonstrated effective preclinical data and has recently received UK approval for their groundbreaking CRISPR-based drug, exa-cel, which is a positive sign[Yahoo, , Yahoo].


Show historical bullish cases

Bearish Case: Stock performance has been slow with recent layoffs and a potential leadership disruption could impact the firm's successes, alongside the competition and market uncertainty that also poses a risk[Helium, Helium, Helium, Helium, fiercebiotech.com].


Show historical bearish cases

Takeaway: CRISPR Therapeutics' future largely depends on the imminent FDA approvals and the success of their broad pipeline. However, challenges persist from ongoing market volatility and potential competition[Helium, Helium, Helium, Helium].


Show historical takeaways

Potential Outcomes:

1. FDA approval in Dec'23 or Mar'24 for exa-cel (70-80%) could significantly raise stock price[Helium, Helium, Helium];

2. Ongoing market volatility and slow growth potentially affecting stock (50%)[Helium, Helium];

3. Positive results and uptake from the recent UK approval could bolster performance (60%) due to the perceived success[Yahoo];

4. Negative impact from loss of co-founder and potential leadership disruption affecting growth and development (30%) could unsettle investors[Helium].


November 25, 2023


CRISPR Therapeutics Forecast

[CRSP]  CRISPR Therapeutics
Price Forecast: BULLISH    Price Action: RANDOM (?)



Make More Profitable Trades with CRSP Forecasts + Trading Strategies







CRSP Balanced News:


















Correlated Stock Forecasts

Assets that tend to move strongly with CRSP



PAGS Forecast + Options Trading Strategies   [PAGS]  PagSeguro Digital (0.79)


CWH Forecast + Options Trading Strategies   [CWH]  Camping World (0.74)


ASML Forecast + Options Trading Strategies   [ASML]  New York Shares (0.71)


HST Forecast + Options Trading Strategies   [HST]  Host Hotels & Resorts (0.68)


INVH Forecast + Options Trading Strategies   [INVH]  Invitation Homes (0.68)



Uncorrelated Stock Forecasts

Assets with little price relationship to CRSP



ARCB Forecast + Options Trading Strategies   [ARCB]  ArcBest (-0.0)


LYB Forecast + Options Trading Strategies   [LYB]  LyondellBasell Industries (0.0)


FVRR Forecast + Options Trading Strategies   [FVRR]  Fiverr (0.0)


MRNA Forecast + Options Trading Strategies   [MRNA]  Moderna (-0.0)


URA Forecast + Options Trading Strategies   [URA]  Global X Uranium (-0.0)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against CRSP



PGR Forecast + Options Trading Strategies   [PGR]  Progressive (-0.43)


UCO Forecast + Options Trading Strategies   [UCO]  ProShares Ultra Bloomberg Crude Oil (-0.43)


AMGN Forecast + Options Trading Strategies   [AMGN]  AMGEN (-0.48)


TWM Forecast + Options Trading Strategies   [TWM]  ProShares UltraShort Russell2000 (-0.49)


DHT Forecast + Options Trading Strategies   [DHT]  DHT (-0.52)


CRSP News over Time





Click points to explore news by date. News sentiment ranges from -10 (very negative) to +10 (very positive) where 0 is neutral.

Most Recent CRSP News